+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Antithrombotic Drugs Global Market Opportunities and Strategies to 2030

  • PDF Icon

    Report

  • April 2020
  • Region: Global
  • The Business Research Company
  • ID: 5018686
Description Jump to:
Antithrombotic Drugs Global Market Opportunities And Strategies To 2030 report from the publisher provides the strategists, marketers and senior management with the critical information they need to assess the global Antithrombotic Drugs market.

Reasons to Purchase
  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.

Description:
Where is the largest and fastest growing market for the antithrombotic drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global antithrombotic drugs opportunities and strategies to 2030 report from the publisher answers all these questions and many more.

The report covers the following chapters:
1. Executive Summary –The executive summary section of the report gives a brief overview and summary of the report

2. Report Structure – This section gives the structure of the report and the information covered in the various sections.

3. Introduction -The introduction section of the report gives brief introduction about segmentation by geography and segmentation by type.

4. Market Characteristics –The market characteristics section of the report defines and explains the antithrombotic drugs market. This chapter includes different goods covered in the report and basic definitions.

5. Global Market Size And Growth – This section contains the global historic (2015-2019) and forecast (2019-2022) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods.

6. Regional And Country Analysis – This section contains the historic (2015-2019), forecast (2019-2022) market value and growth and market share comparison by region and countries.

7. Market Segmentation –This section contains the market values (2014-2022) and analysis for different segments in the market.

8. Regional Market Size And Growth–This section contains the region’s market size (2019), historic and forecast (2019-2022) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa).

9. Competitive Landscape – This section covers details on the competitive landscape of the global antithrombotic drugs market, estimated market shares and company profiles of the leading players.

10. Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.

11. Trends And Strategies – This chapter describes the major trends shaping the global antithrombotic drugs market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.

12. Future Outlook and Potential Analysis – This section includes conclusions and recommendations based on findings of the research. This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.

13. Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:
By Type Of Product: Anticoagulant Drugs; Antiplatelet Drugs; Thrombolytic Drugs
By Application: Blood Clot And Thromboembolic Treatment; Hyperlipidemia Treatment; Prophylactic Treatment; Other Applications
By Class: Fondaparinux; Heparin; Apixaban; Dabigatran; Rivaroxaban; Others
By Route Of Administration: Oral Route; Parenteral Route
By Distribution Channel: General Pharmacies; Hospital Pharmacies; Online Retailers

Companies Mentioned: Bristol Myers Squibb; Bayer AG; Pfizer; Johnson & Johnson; Boehringer-Ingelheim

Countries: China, India, Japan, Australia, Indonesia, South Korea, USA, UK, Germany, France, Russia, Brazil

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: one five-year historic, two four-year forecast, and one six-year further forecast

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


This product will be delivered within 1-3 business days.

Table of Contents

1. Antithrombotic Drugs Market Executive Summary2. Table of Contents3. List of Figures4. List of Tables5. Report Structure
6. Antithrombotic Drugs Market Characteristics
6.1. Market Segmentation By Type Of Product
6.1.1. Anticoagulant Drugs
6.1.2. Antiplatelet Drugs
6.1.3. Thrombolytic Drugs
6.2. Market Segmentation By Application
6.2.1. Blood Clot And Thromboembolic Treatment
6.2.2. Hyperlipidemia Treatment
6.2.3. Prophylactic Treatment
6.2.4. Other Applications
6.3. Market Segmentation By Class
6.3.1. Fondaparinux
6.3.2. Heparin
6.3.3. Apixaban
6.3.4. Dabigatran
6.3.5. Rivaroxaban
6.3.6. Others
6.4. Market Segmentation By Route Of Administration
6.4.1. Oral
6.4.2. Parenteral
6.5. Market Segmentation By Distribution Channel
6.5.1. Hospital Pharmacies
6.5.2. Online Retailers
6.5.3. Drug Stores
7. Global Antithrombotic Drugs Market Size And Growth
7.1. Historic And Forecast Market Growth, Value ($ Million)
7.1.1. Historic Drivers Of The Market 2015-2019
7.1.2. Historic Restraints Of The Market 2015-2019
7.1.3. Forecast Drivers Of The Market 2019-2022
7.1.4. Forecast Restraints Of The Market 2019-2022
8. Global Antithrombotic Drugs Market Segmentation
8.1. Global Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
8.2. Global Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
8.3. Global Antithrombotic Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
8.4. Global Antithrombotic Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
8.5. Global Antithrombotic Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
9. Antithrombotic Drugs Market, Regional And Country Analysis
9.1. Global Antithrombotic Drugs Market, By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
9.2. Global Antithrombotic Drugs Market, By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
10. Asia-Pacific Antithrombotic Drugs Market
10.1. Asia-Pacific Antithrombotic Drugs Market Overview
10.1.1. Region Information
10.1.2. Market Information
10.1.3. Background Information
10.1.4. New Drug Approvals
10.1.5. Government Initiatives
10.1.6. Regulatory Bodies
10.1.7. Regulations
10.1.8. Associations
10.1.9. Taxes Levied
10.1.10. Corporate Tax
10.1.11. Investments
10.1.12. Major Companies
10.2. Asia-Pacific Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
10.3. Asia-Pacific Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
10.4. Asia-Pacific Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
10.5. Asia-Pacific Antithrombotic Drugs Market: Country Analysis
10.6. China Antithrombotic Drugs Market
10.7. China Antithrombotic Drugs Market Overview
10.7.1. Country Information
10.7.2. Market Information
10.7.3. Background Information
10.7.4. New Drug Approvals
10.7.5. Government Initiatives
10.7.6. Regulatory Bodies
10.7.7. Regulations
10.7.8. Associations
10.7.9. Taxes Levied
10.7.10. Corporate Tax
10.7.11. Investments
10.7.12. Major Companies
10.8. China Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
10.9. China Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
10.10. China Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
10.11. India Antithrombotic Drugs Market
10.12. India Antithrombotic Drugs Market Overview
10.12.1. Country Information
10.12.2. Market Information
10.12.3. Background Information
10.12.4. New Drug Approvals
10.12.5. Government Initiatives
10.12.6. Regulatory Bodies
10.12.7. Regulations
10.12.8. Associations
10.12.9. Taxes Levied
10.12.10. Corporate Tax
10.12.11. Investments
10.12.12. Major Companies
10.13. India Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
10.14. India Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
10.15. India Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
10.16. Japan Antithrombotic Drugs Market
10.17. Japan Antithrombotic Drugs Market Overview
10.17.1. Region Information
10.17.2. Market Information
10.17.3. Background Information
10.17.4. Government Initiatives
10.17.5. Regulatory Bodies
10.17.6. Regulations
10.17.7. Associations
10.17.8. Taxes Levied
10.17.9. Corporate Tax
10.17.10. Investments
10.17.11. Major Companies
10.18. Japan Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
10.19. Japan Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
10.20. Japan Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
10.21. Australia Antithrombotic Drugs Market
10.22. Australia Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
10.23. Australia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
10.24. Australia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
10.25. Indonesia Antithrombotic Drugs Market
10.26. Indonesia Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
10.27. Indonesia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
10.28. Indonesia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
10.29. South Korea Antithrombotic Drugs Market
10.30. South Korea Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
10.31. South Korea Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
10.32. South Korea Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
11. Western Europe Antithrombotic Drugs Market
11.1. Western Europe Antithrombotic Drugs Market Overview
11.1.1. Region Information
11.1.2. Market Information
11.1.3. Background Information
11.1.4. New Drug Approvals
11.1.5. Government Initiatives
11.1.6. Regulatory Bodies
11.1.7. Regulations
11.1.8. Associations
11.1.9. Taxes Levied
11.1.10. Corporate Tax
11.1.11. Investments
11.1.12. Major Companies
11.2. Western Europe Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
11.3. Western Europe Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
11.4. Western Europe Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
11.5. Western Europe Antithrombotic Drugs Market: Country Analysis
11.6. UK Antithrombotic Drugs Market
11.7. UK Antithrombotic Drugs Market Overview
11.7.1. Region Information
11.7.2. Market Information
11.7.3. Background Information
11.7.4. New Drug Approvals
11.7.5. Government Initiatives
11.7.6. Regulatory Bodies
11.7.7. Regulations
11.7.8. Associations
11.7.9. Taxes Levied
11.7.10. Corporate Tax
11.7.11. Investments
11.7.12. Major Companies
11.8. UK Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
11.9. UK Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
11.10. UK Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
11.11. Germany Antithrombotic Drugs Market
11.12. Germany Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
11.13. Germany Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
11.14. Germany Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
11.15. France Antithrombotic Drugs Market
11.16. France Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
11.17. France Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
11.18. France Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
12. Eastern Europe Antithrombotic Drugs Market
12.1. Eastern Europe Antithrombotic Drugs Market Overview
12.1.1. Region Information
12.1.2. Market Information
12.1.3. Background Information
12.1.4. New Drug Approvals
12.1.5. Government Initiatives
12.1.6. Regulatory Bodies
12.1.7. Regulations
12.1.8. Associations
12.1.9. Taxes Levied
12.1.10. Corporate Tax
12.1.11. Investments
12.1.12. Major Companies
12.2. Eastern Europe Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
12.3. Eastern Europe Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
12.4. Eastern Europe Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
12.5. Eastern Europe Antithrombotic Drugs Market: Country Analysis
12.6. Russia Antithrombotic Drugs Market
12.7. Russia Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
12.8. Russia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
12.9. Russia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
13. North America Antithrombotic Drugs Market
13.1. North America Antithrombotic Drugs Market Overview
13.1.1. Region Information
13.1.2. Market Information
13.1.3. Background Information
13.1.4. New Drug Approvals
13.1.5. Government Initiatives
13.1.6. Regulatory Bodies
13.1.7. Regulations
13.1.8. Associations
13.1.9. Taxes Levied
13.1.10. Corporate Tax
13.1.11. Investments
13.1.12. Major Companies
13.2. North America Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
13.3. North America Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
13.4. North America Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
13.5. North America Antithrombotic Drugs Market: Country Analysis
13.6. USA Antithrombotic Drugs Market
13.7. USA Antithrombotic Drugs Market Overview
13.7.1. Country Information
13.7.2. Market Information
13.7.3. Background Information
13.7.4. New Drug Approvals
13.7.5. Government Initiatives
13.7.6. Regulatory Bodies
13.7.7. Regulations
13.7.8. Associations
13.7.9. Taxes Levied
13.7.10. Corporate Tax
13.7.11. Investments
13.7.12. Major Companies
13.8. USA Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
13.9. USA Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
13.10. USA Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
14. South America Antithrombotic Drugs Market
14.1. South America Antithrombotic Drugs Market Overview
14.1.1. Region Information
14.1.2. Market Information
14.1.3. Background Information
14.1.4. Government Initiatives
14.1.5. Regulatory Bodies
14.1.6. Regulations
14.1.7. Associations
14.1.8. Taxes Levied
14.1.9. Corporate Tax
14.1.10. Major Companies
14.2. South America Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
14.3. South America Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
14.4. South America Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
14.5. South America Antithrombotic Drugs Market: Country Analysis
14.6. Brazil Antithrombotic Drugs Market
14.7. Brazil Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
14.8. Brazil Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
14.9. Brazil Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
15. Middle East Antithrombotic Drugs Market
15.1. Middle East Antithrombotic Drugs Market Overview
15.1.1. Region Information
15.1.2. Market Information
15.1.3. Government Initiatives
15.1.4. Regulatory Bodies
15.1.5. Regulations
15.1.6. Associations
15.1.7. Taxes Levied
15.1.8. Corporate Tax
15.1.9. Investments
15.1.10. Major Companies
15.2. Middle East Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
15.3. Middle East Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
15.4. Middle East Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
16. Africa Antithrombotic Drugs Market
16.1. Africa Antithrombotic Drugs Market Overview
16.1.1. Region Information
16.1.2. Market Information
16.1.3. Government Initiatives
16.1.4. Regulatory Bodies
16.1.5. Regulations
16.1.6. Associations
16.1.7. Taxes Levied
16.1.8. Corporate Tax
16.1.9. Major Companies
16.2. Africa Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
16.3. Africa Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
16.4. Africa Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
17. Global Antithrombotic Drugs Market Competitive Landscape
17.1. Company Profiles
17.2. Bristol Myers Squibb
17.2.1. Company Overview
17.2.2. Products And Services
17.2.3. Business Strategy
17.2.4. Financial Overview
17.3. Bayer AG
17.3.1. Company Overview
17.3.2. Products And Services
17.3.3. Business Strategy
17.3.4. Financial Overview
17.4. Pfizer
17.4.1. Company Overview
17.4.2. Products And Services
17.4.3. Business Strategy
17.4.4. Financial Overview
17.5. Johnson & Johnson
17.5.1. Company Overview
17.5.2. Products And Services
17.5.3. Business Strategy
17.5.4. Financial Overview
17.6. Boehringer-Ingelheim GmbH
17.6.1. Company Overview
17.6.2. Products And Services
17.6.3. Business Strategy
17.6.4. Financial Overview
18. Key Mergers And Acquisitions In The Antithrombotic Drugs Market
18.1. AMAG Pharmaceuticals Acquired Perosphere Pharmaceuticals
18.2. Johnson & Johnson Acquired Bristol-Myers Cardiovascular Disease Program
18.3. Sanofi Acquired Bioverativ Inc.
18.4. AstraZeneca Acquired Antithrombotic Candidate From APT Therapeutics
18.5. Bristol-Myers Acquired Cardioxyl's Heart Failure Therapy
18.6. Janssen Acquired XO1 Limited
19. Antithrombotic Drugs Market Trends And Strategies
19.1. Novel Oral Anti-coagulants(NOACs) To Prevent Thrombosis
19.2. Tranexamic Acid To Prevent Postpartum Hemorrhage
19.3. New Antithrombotic Biologics To Cure Blood Vessel Wall Injury
20. Antithrombotic Drugs Market, Product Pipeline Analysis
21. Antithrombotic Drugs Market Future Outlook and Potential Analysis
21.1. Global Antithrombotic Drugs Market In 2022 – Countries Offering Most New Opportunities
21.2. Global Antithrombotic Drugs Market In 2022- Segments Offering Most New Opportunities
21.3. Global Antithrombotic Drugs Market In 2022 – Growth Strategies
21.3.1. Market Trend Based Strategies
21.3.2. Competitor Strategies
22. AntithromboticDrugs Market, Conclusions And Recommendations
22.1. Conclusions
22.2. Recommendations
22.2.1. Product
22.2.2. Price
22.2.3. Place
22.2.4. Promotion
23. Appendix
23.1. Market Data Sources
23.2. Research Methodology
23.3. Currencies
23.4. Research Inquiries
23.5. About the Publisher
24. Copyright and Disclaimer

Executive Summary

This report describes and evaluates the global antithrombotic drugs market. It covers one five-year period, two four-year periods and one six-year period including, 2015 to 2019, termed the historic period, and 2019 to 2022 forecast period, 2022-2025 forecast period and 2025 -2030 the forecast period.

The global antithrombotic drugs market reached a value of nearly $35,801.9 million in 2019, having grown at a compound annual growth rate (CAGR) of 9.8% since 2015, and is expected to grow at a CAGR of 7.7% to nearly $44,702.6 million by 2022.Also the market is expected to growth to $55,172.2 million in 2025 at a CAGR of 7.3% and to $ 72,996.5 million in 2030 at a CAGR of 5.8%.

Growth in the historic period resulted from aging population and emerging markets. Factors that negatively affected growth in the historic period were patent expiry of drugs, pricing, high costs of drug approval.

Going forward, busy life styles, technology and faster economic growth is expected to drive the market. Factor that could hinder the growth of the antithrombotic drugs market in the future include pricing pressures and side effects of antithrombotic drugs.

The antithrombotic drugs market is segmented by type of product into anti-coagulant drugs, anti-fibrinolytics drugs and anti-platelet drugs. The anticoagulant drugs market was the largest segment of the antithrombotic drugs market, accounting for $19,536.3 million or 54.6% of the total market in 2019. The antiplatelet drugs market is expected to be the fastest-growing segment going forward at a CAGR of 8.7%.

The antithrombotic drugs market is segmented by type of application into hyperlipidemia treatment, blood clot and thromboembolic treatment drugs, prophylactic treatment and other applications. The blood clot and thromboembolic treatment drugs was the largest and fastest growing segment of the antithrombotic drugs market by application, accounting for $12,844.2 million or 35.9% of the total market in 2019.

The antithrombotic drugs market is segmented by drug class into heparin, apixaban, rivaroxaban, dabigatran, fondaparinux, and others. The heparin was the largest segment of the antithrombotic drugs market by drug class, accounting for $13,809.1 million or 38.6% of the total market in 2019. The apixaban market is expected to be the fastest-growing segment going forward at a CAGR of 12.5%.

The antithrombotic drugs market is segmented by route of administration into oral and parenteral route. The oral was largest segment of the antithrombotic drugs market, accounting for $25,362.5 million or 70.8% of the total market in 2019, and is expected to be the fastest-growing segment going forward at a CAGR of 8.2%.

The antithrombotic drugs market is segmented by distribution channel into general pharmacies, hospital pharmacies and online retailers. The general pharmacies was largest segment of the antithrombotic drugs market, accounting for $22,284.3 million or 62.2% of the total market in 2019. The online retailers’ distribution channel is expected to be the fastest-growing segment going forward at a CAGR of 13.0%.

Asia-Pacific was the largest region in the antithrombotic drugs market, accounting for 36.1% of the global market in 2019. It was followed by North America, Western Europe and the other regions. Going forward, the fastest growing regions in the antithrombotic drugs market will be Asia-Pacific and the Middle East, where growth will be at CAGRs of 10.7% and 8.0% respectively from 2019-2022.

The global antithrombotic drugs market is fairly concentrated, with a small number of large players. The top ten competitors in the market made up to 62% of the total market in 2018. Major players in the market include Bristol Myers Squibb, Bayer AG, Pfizer, Johnson & Johnson, Boehringer-Ingelheim and others.

The top growth potential in the antithrombotic drugs market will arise in anti-coagulant drugs market, which will gain $4,859.6 million of global annual sales by 2022. The antithrombotic drugs market size will gain the most in China at $2,674.0 million.

Market-trend-based strategies for the antithrombotic drugs market include developing effective therapies that replace traditional therapies, developing tranexamic acid drug and new patented drugs to offer improved treatment to thrombosis patients. Player-adopted strategies in the antithrombotic drugs industry include strengthening portfolio through mergers and acquisitions and investing in research and development for development of new drug regimen for thrombotic conditions.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Acetlion Pharmaceuticals
  • Actinova Ltd
  • Aspen Czech Republic
  • Aspen Pharma Brasil
  • Baxter International Inc
  • Bayer AG
  • Boehringer-Ingelheim
  • Bristol Myers Squibb
  • China National Pharmaceutical Group Corp.
  • Cristália.
  • Dr. Reddy's Laboratories
  • Eisai Co., Ltd
  • Elder Pharmaceuticals Ltd
  • Generium
  • Glenmark Pharmaceuticals Limited
  • Janssen Pharmaceuticals, Inc.
  • Johnson & Johnson
  • JP Indústria Pharmaceutica SA
  • Julphar
  • Medical Appliances Corporation (SPIMACO)
  • Merck & Co., Inc
  • Merck Serono Middle East
  • Nippon Boehringer Ingelheim Co ., Ltd
  • Novartis
  • Petrovax LLC
  • Pfizer
  • Ranbaxy Laboratories Limited
  • SAJA Pharmaceuticals
  • Saudi Pharmaceutical Industries
  • Servier
  • Servier Canada Inc
  • Shanghai Fosun Pharmaceutical Co., Ltd.
  • Shanghai Pharmaceuticals Holding Co., Ltd
  • Shenzhen Xinlitai Pharmaceutical Co., Ltd.
  • Sun Pharmaceutical Industries Ltd
  • Takeda Pharmaceutical Co., Ltd.,
  • Valeo Pharma Inc
  • Yuyu Pharma Inc.
  • Zhengda Tianqing Pharmaceutical Group Co.,Ltd.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Global Antithrombotic Drugs Market 2023-2027 - Product Image

Global Antithrombotic Drugs Market 2023-2027

  • Report
  • 156 Pages
  • Global
From
Antithrombotic Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Antithrombotic Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 89 Pages
  • Global
From
Global Hemophilia Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Type (Hemophilia A, Hemophilia B), By Treatment Type (Prophylaxis, On-demand, and Cure), By Therapy, By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Global Hemophilia Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Type (Hemophilia A, Hemophilia B), By Treatment Type (Prophylaxis, On-demand, and Cure), By Therapy, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • 311 Pages
  • Global
From
Asia Pacific Antiplatelet Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, and Injectable), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Image

Asia Pacific Antiplatelet Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, and Injectable), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • 143 Pages
  • Asia Pacific
From
Ullmann's Pharmaceuticals, 2 Volume Set. Edition No. 1 - Product Image

Ullmann's Pharmaceuticals, 2 Volume Set. Edition No. 1

  • Book
  • 1040 Pages
Copyright © 2002-2024 Research and Markets. All Rights Reserved.